Skip to content

Advances in next-generation sequencing technology and computational data analysis have revolutionized efforts to identify tumor-specific mutant antigens. These altered, potentially immunogenic proteins may prove to be an important target for immunotherapies. In this Cell Press Webinar, Nicholas McGranahan (University College London) and Gerald Linette (University of Pennsylvania) will review progress made and future applications of this important area of cancer immunogenomics.

Fill Out Form to Access Webinar

Your email address is never shared with third parties.

Date & Time
10:00 AM PT
North America
University College London and University of Pennsylvania
Nicholas McGranahan and Gerald P. Linette
Cancer Research
Watch Now